How to buy 908 Devices stock (908 Devices)

Boston-based research device developer 908 Devices completed its $125 million initial public offering, and its shares are now available to trade on the Nasdaq under the ticker "MASS." Shares are available for limit orders via Robinhood.

Our top picks for where to buy 908 Devices stock

Buy 908 Devices stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

908 Devices stock price (NASDAQ: MASS)

Use our graph to track the performance of MASS stocks over time.

908 Devices shares at a glance

• Key figures

Information last updated 2024-12-12.

Latest market close	$1.88
52-week range	$2.18 - $12.51
50-day moving average more info button	$3.09
200-day moving average more info button	$4.90
Wall St. target price	$5.67
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-1.79

Is it a good time to buy 908 Devices stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

908 Devices price performance over time

Historical closes compared with the close of $2.15 from 2024-12-16

1 week (2024-12-12)	1.42%
1 month (2024-11-19)	-13.31%
3 months (2024-09-19)	-44.01%
6 months (2024-06-18)	-60.84%

1 year (2023-12-19)	-76.08%
2 years (2022-12-19)	-73.81%
3 years (2021-12-17)	26.17
5 years (2019-12-15)	N/A

908 Devices financials

Revenue TTM	$55.2 million
Gross profit TTM	$26 million
Return on assets TTM	-15.56%
Return on equity TTM	-40%
Profit margin	-109.11%
Book value	$3.78
Market Capitalization more info button	$78.7 million

TTM: trailing 12 months

908 Devices share dividends

We're not expecting 908 Devices to pay a dividend over the next 12 months.

You may also wish to consider:

• ResMed (RMD.US) (0.86% forward annual dividend yield)
• Novartis AG ADR (NVS.US) (3.81% forward annual dividend yield)

908 Devices share price volatility

Over the last 12 months, 908 Devices's shares have ranged in value from as little as $2.18 up to $12.51. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while 908 Devices's is 0.976. This would suggest that 908 Devices's shares are less volatile than average (for this exchange).

To put 908 Devices's beta into context you can compare it against those of similar companies.

• Quidel Corporation (QDEL.US): 0.116
• ResMed (RMD.US): 0.687
• Novartis AG ADR (NVS.US): 0.505

908 Devices overview

908 Devices Inc. , a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Frequently asked questions

null
What percentage of 908 Devices is owned by insiders or institutions?
Currently 7.598% of 908 Devices shares are held by insiders and 69.745% by institutions. How many people work for 908 Devices?
Latest data suggests 230 work at 908 Devices. When does the fiscal year end for 908 Devices?
908 Devices's fiscal year ends in December. Where is 908 Devices based?
908 Devices's address is: 645 Summer Street, Boston, MA, United States, 02210 What is 908 Devices's ISIN number?
908 Devices's international securities identification number is: US65443P1021